OneSource Specialty Pharma Ltd
ONESOURCE
Company Profile
Business description
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture, and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company’s reportable segments are Unit 1 - R&D and Unit 2 : CDMO-1 (Contract Development & Manufacturing Organization); and Unit 3: Multimodal Facility and CDMO-2.
Contact
Bannerghatta Road
Star 1, Opp IIM Bangalore
Bilekahalli
BangaloreKA560076
INDT: +91 8067840444
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2025
Employees
Stocks News & Analysis
stocks
DeepSeek revelation hits US chip stocks, ASX data centres and uranium
Shockwaves from Monday's AI stock panic in the US were largely confined to two ASX industries.
video
What does a weak Aussie dollar mean for investors?
Morningstar Investment Management's Chief Investment Officer for Asia Pacific weighs in on the weak Aussie dollar and what this could mean for investors.
stocks
AI stock rout: The US selloff in 4 charts
Worries about Western AI dominance permeated the markets, with Nvidia stock plunging 17% alongside other chipmakers, utilities, and more.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,700.70 | 56.20 | 0.65% |
| CAC 40 | 7,872.48 | 24.89 | -0.32% |
| DAX 40 | 21,637.53 | 206.95 | 0.97% |
| Dow JONES (US) | 44,784.16 | 66.19 | -0.15% |
| FTSE 100 | 8,557.81 | 23.94 | 0.28% |
| HKSE | 20,225.11 | 27.34 | 0.14% |
| NASDAQ | 19,575.87 | 157.72 | -0.80% |
| Nikkei 225 | 39,414.78 | 397.91 | 1.02% |
| NZX 50 Index | 13,003.04 | 45.89 | 0.35% |
| S&P 500 | 6,038.55 | 29.15 | -0.48% |
| S&P/ASX 200 | 8,447.00 | 47.90 | 0.57% |
| SSE Composite Index | 3,250.60 | 2.03 | -0.06% |